The need to respond at scale and pace to the coronavirus pandemic has created unprecedented collaboration between the NHS and the pharmaceutical and medical devices sector.

Projects, including clinical trials and new service models, that would usually take months to deliver were in place in days or weeks.

HSJ put together an expert panel to explore the nature of this collaboration – and what lessons it contains for the future.

Joining HSJ editor Alastair McLellan, were NHS Providers chief executive Chris Hopson, Johnson and Johnson UK medical devices managing director Hugo Breda and Roche UK medical director Rav Seeuruthun.

The full webinar can be viewed here.